News

Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market
Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...
Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model
Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in ...
Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
Skye shares surge after new data shows nimacimab reduces weight over 30% with tirzepatide, with stable potency and promising ...
News-Medical.Net on MSN58m
New findings highlight a shifting landscape for weight loss and glucose managing medications
When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.
Knowridge Science Report3h
New study confirms long-term success of weight-loss drug Tirzepatide
A new study has found that the weight-loss drug tirzepatide can help people lose a significant amount of weight and keep it ...
FuturHealth Strengthens Executive Team to Accelerate Growth and Engagement on Its Weight-Loss Platform
FuturHealth, a leader in personalized weight-loss solutions, today announced the appointment of Keith Koch as Executive Vice President of Growth Product & Experience Design. Koch, a veteran in digital ...
Study captures sharp uptake in use of new weight loss and glucose-lowering medications
When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.